Expert Brief: Medical Management of NETs
OR
Learning Objectives
- Review current concepts and medical treatment options for neuroendocrine tumors
- Summarize the current safety and efficacy data of the various medical approaches in the management
of metastatic neuroendocrine tumors - Recognize the clinical features associated with carcinoid syndrome
- Apply a multidisciplinary approach to the management of patients with neuroendocrine tumors
- Review clinical trial data and ongoing studies evaluating novel management strategies for the treatment of neuroendocrine tumors
Speakers
Dr. Rachel Goodwin
Dr. Simron Singh
This program has been made possible through unrestricted support from Ipsen
Studies/trials discussed:
- PROMID trial
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
- CLARINET study
- NETTER-1 trial
- NETTER-2 trial
- CLARINET forte phase 2 study
- CLARINET forte trial
